The UK government mandates surveillance for MRSA, MSSA, and C. difficile from February 2027 to February 2028.
Collaboration among healthcare providers and public health authorities is essential for effective data collection.
Swipe up or tap below to access verified documents, statutory dockets, and interactive forensic breakdowns on DotMR.